Companies: 10,795·Total market cap: $144.5T
NanoSphere Health Sciences Inc.

NanoSphere Health Sciences Inc.

NSHSFOTCHealthcare● Active
$0.00
$-0.01(-57.29%)
Market Cap$42128
P/E Ratio
52W High$0.02
52W Low$0.0038

NanoSphere Health Sciences Inc. (NSHSF) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

nshsf · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for NanoSphere Health Sciences Inc. (NSHSF) measures how much investors pay for each dollar of the company's trailing earnings. NSHSF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.01.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
EPS (TTM)
-$0.01
TTM · diluted EPS
PEG Ratio
0.01
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · NanoSphere Health Sciences Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2006 – 2025 · Annual
PE Ratio (TTM)
5Y Avg 546.6x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
NanoSphere Health Sciences Inc.
NanoSphere Health Sciences Inc.You
NSHSF
$0MN/A-$0.01
BetterLife Pharma Inc.
BetterLife Pharma Inc.
BETRF
$7MN/A-$0.01
Bioxytran, Inc.
Bioxytran, Inc.
BIXT
$3MN/A-$0.02
BioVaxys Technology Corp.
BioVaxys Technology Corp.
BVAXF
$3MN/A-$0.20
Chimeric Therapeutics Limited
Chimeric Therapeutics Limited
CHMMF
$4MN/A-$0.77
Mosaic ImmunoEngineering Inc.
Mosaic ImmunoEngineering Inc.
CPMV
$5MN/A-$0.10
Curative Biotechnology, Inc.
Curative Biotechnology, Inc.
CUBT
$11MN/A-$0.00

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 20 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-0.01
2024-12-31
FY2024
1092.54x$0.00
2023-12-31
FY2023
$-0.02
2022-12-31
FY2022
$-0.03
2021-12-31
FY2021
$-0.05
2020-12-31
FY2020
$-0.11
2019-12-31
FY2019
$-0.65
2018-12-31
FY2018
$-0.93
2017-12-31
FY2017
$-18.02
2016-12-31
FY2016
$-0.43

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for NanoSphere Health Sciences Inc. (NSHSF) measures how much investors pay for each dollar of the company's trailing earnings. NSHSF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.01.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ -$0.01 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

NSHSF pe ratio · 6 questions

NSHSF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.01. Data sourced from Financial Modeling Prep via NSHSF's SEC 10-K and 10-Q filings.

NSHSF PE ratioWhat is NSHSF PE ratioCurrent PE ratio of NSHSFNSHSF PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · NanoSphere Health Sciences Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09